Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
about
Fluorescent imaging of cancerous tissues for targeted surgery.Laparoscopic Fluorescent Visualization of the Ureter With Intravenous IRDye800CW.The status of contemporary image-guided modalities in oncologic surgeryUltrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer.Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In Vivo.Synthesis and biological evaluation of panitumumab-IRDye800 conjugate as a fluorescence imaging probe for EGFR-expressing cancers.Rapid detection and destruction of squamous cell carcinoma of the head and neck by nano-quadrapeutics.Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment.Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery.A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugsAntibody-based imaging strategies for cancer.Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients.Role of near-infrared fluorescence imaging in head and neck cancer surgery: from animal models to humans.Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer.Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer.Deglycosylation of mAb by EndoS for improved molecular imaging.Beyond the margins: real-time detection of cancer using targeted fluorophores.Optical Surgical Navigation for Precision in Tumor Resections.Dynamic optical contrast imaging as a novel modality for rapidly distinguishing head and neck squamous cell carcinoma from surrounding normal tissue.Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients.Impact of C4'-O-Alkyl Linker on in Vivo Pharmacokinetics of Near-Infrared Cyanine/Monoclonal Antibody Conjugates.Characterizing the Utility and Limitations of Repurposing an Open-Field Optical Imaging Device for Fluorescence-Guided Surgery in Head and Neck Cancer Patients.Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision.Application of Fluorescence-Guided Surgery to Subsurface Cancers Requiring Wide Local Excision: Literature Review and Novel Developments Toward Indirect Visualization.Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use.Production of a germline-humanized cetuximab scFv and evaluation of its activity in recognizing EGFR- overexpressing cancer cells.Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumab.Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.A Real-Time Near-Infrared Fluorescence Imaging Method for the Detection of Oral Cancers in Mice Using an Indocyanine Green-Labeled Podoplanin Antibody.Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.Operative margin control with high-resolution optical microendoscopy for head and neck squamous cell carcinoma.Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques.Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation.Advancing theranostics with tumor-targeting peptides for precision otolaryngology.Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging
P2860
Q26830905-9DFE1CFC-6CAF-4D51-B4CD-9462C55672FEQ27309385-D6451412-934E-4A96-918B-E627139EF085Q30394594-5BD192DF-5AB3-47C8-8B47-728ED5A0162CQ30415659-FEE6D1FE-0443-4350-AA40-7481EB034E78Q33925013-93182B61-EE61-4603-9BC3-1E486F412EC3Q34563045-8AB4543B-EA23-494A-988D-431D7B12B512Q35560212-0B128F04-9BD4-4027-8F95-3101C6FC1F94Q35909379-6696A72A-1C61-4B3F-AE09-AE436002A43EQ36540727-D3F9D8C4-0389-4C31-B37F-B4669C5B4F64Q37002080-FC7E6F53-ECB5-4F63-927A-69B98FD472BFQ37389699-E991C825-33B8-4FB4-A5D4-C0E39562148BQ38206520-55E5A799-838D-43A4-A1D1-7B8ACD38234CQ38218986-2862E2EE-E892-4D31-B341-A8C57510ABB1Q38225877-BF23392B-BB0A-4609-B807-89E03952C79AQ38239193-D33E79AD-D2B6-40A1-AB3E-E2E9DA8BBF3CQ38240998-03D84F40-52CB-4389-AEEC-7FC30E4E5611Q38748970-81C4740B-9837-40CB-BB7C-78E11326EDCFQ38818115-766EE266-EFB1-4F0D-BC8B-1B8474B1C1E6Q38964828-BB596B6D-A5ED-46A3-AC71-94D2CC88B877Q39091749-D96CD833-3CBC-419D-A52C-13AC53C99CAEQ39167489-606328ED-6AC2-4DF8-9A16-1996E9CCB432Q39267233-4279D2F3-07A9-4776-8957-D26EC0C22F27Q40471529-6C3C0B82-372A-4B7B-8A77-E5E05A37B0C7Q41553931-8448F287-F904-4AF2-9998-5D2BD2C34089Q42324522-CC0059E8-2919-4F01-B933-00F8A64D1A31Q47222617-004F6776-353F-4F51-8156-A143A344F0DDQ47731667-5CD093E6-2B0E-46A1-A1DC-D7488AE6E826Q47928453-E24F5410-27F7-466C-A9BE-92F181BBE7C5Q49554227-69BD4DAA-4CA7-4C76-872F-DCA9E84F07CBQ49787562-29271EC1-767D-4DC0-9203-3AA794F0911FQ51634494-C10F5DF1-57D3-44C0-BE10-1B774A6EC5CDQ52591453-C9C484D2-DED8-492A-B69F-69C09E53BFDEQ52714380-B3DBFEEA-29B2-42B5-B5A8-6A97E1EF7E62Q52937701-12366B38-C6CD-4468-BFF1-1F641CBD5D75Q53363211-90F3B4C9-B72C-4CB4-8B67-82B0E306C599Q54539778-B8AD54BF-7518-4437-9400-92C78B179D5CQ55006457-C8D8D0BF-4658-420B-908A-FD13E48386F2Q59224446-96E4F318-6383-4E92-B1EE-D52C008D7A5D
P2860
Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preclinical comparison of near ...... neck squamous cell carcinoma.
@en
Preclinical comparison of near ...... neck squamous cell carcinoma.
@nl
type
label
Preclinical comparison of near ...... neck squamous cell carcinoma.
@en
Preclinical comparison of near ...... neck squamous cell carcinoma.
@nl
prefLabel
Preclinical comparison of near ...... neck squamous cell carcinoma.
@en
Preclinical comparison of near ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P1476
Preclinical comparison of near ...... d neck squamous cell carcinoma
@en
P2093
Brian Kulbersh
Eben L Rosenthal
Kristine E Day
Larissa Sweeny
P2860
P2888
P304
P356
10.1007/S11307-013-0652-9
P50
P577
2013-12-01T00:00:00Z